These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9810645)

  • 1. In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: influence of test conditions on minimal inhibitory concentration (MIC) values.
    Boerner J; Failing K; Wittenbrink MM
    Zentralbl Bakteriol; 1995 Nov; 283(1):49-60. PubMed ID: 9810645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies.
    Dever LL; Jorgensen JH; Barbour AG
    J Clin Microbiol; 1992 Oct; 30(10):2692-7. PubMed ID: 1400969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of mezlocillin, meropenem, aztreonam, vancomycin, teicoplanin, ribostamycin and fusidic acid against Borrelia burgdorferi.
    Hunfeld KP; Weigand J; Wichelhaus TA; Kekoukh E; Kraiczy P; Brade V
    Int J Antimicrob Agents; 2001 Mar; 17(3):203-8. PubMed ID: 11282265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New colorimetric microdilution method for in vitro susceptibility testing of Borrelia burgdorferi against antimicrobial substances.
    Hunfeld KP; Kraiczy P; Wichelhaus TA; Schäfer V; Brade V
    Eur J Clin Microbiol Infect Dis; 2000 Jan; 19(1):27-32. PubMed ID: 10706176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of fluoroquinolones against the spirochete Borrelia burgdorferi.
    Kraiczy P; Weigand J; Wichelhaus TA; Heisig P; Backes H; Schäfer V; Acker G; Brade V; Hunfeld KP
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2486-94. PubMed ID: 11502519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of Borrelia burgdorferi isolates to three antibiotics commonly used for treating equine Lyme disease.
    Caol S; Divers T; Crisman M; Chang YF
    BMC Vet Res; 2017 Sep; 13(1):293. PubMed ID: 28962614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics.
    Baradaran-Dilmaghani R; Stanek G
    Infection; 1996; 24(1):60-3. PubMed ID: 8852472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto.
    Sicklinger M; Wienecke R; Neubert U
    J Clin Microbiol; 2003 Apr; 41(4):1791-3. PubMed ID: 12682190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of Borrelia burgdorferi strains isolated in the Czech Republic.
    Janovská D; Hulínská D; Godová T
    Cent Eur J Public Health; 2001 Feb; 9(1):38-40. PubMed ID: 11243589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of European human Borrelia burgdorferi sensu stricto strains to antimicrobial agents.
    Veinović G; Cerar T; Strle F; Lotrič-Furlan S; Maraspin V; Cimperman J; Ružić-Sabljić E
    Int J Antimicrob Agents; 2013 Mar; 41(3):288-91. PubMed ID: 23312603
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Koetsveld J; Draga ROP; Wagemakers A; Manger A; Oei A; Visser CE; Hovius JW
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro susceptibility of Borrelia burgdorferi and Borrelia hermsii to ten antimicrobial agents.
    Sambri V; Massaria F; Cevenini R; La Placa M
    J Chemother; 1990 Dec; 2(6):348-50. PubMed ID: 2093104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates.
    Hunfeld KP; Kraiczy P; Wichelhaus TA; Schäfer V; Brade V
    Int J Antimicrob Agents; 2000 Jun; 15(1):11-7. PubMed ID: 10856671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysis culture for determination of MIC and MBC of benzylpenicillin against Borrelia burgdorferi.
    Stiernstedt SH; Tadesse T; Wretlind B
    APMIS; 1999 Apr; 107(4):380-2. PubMed ID: 10230690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of faropenem, ertapenem, imipenem and meropenem against Borrelia burgdorferi s.l.
    Rödel R; Freyer A; Bittner T; Schäfer V; Hunfeld KP
    Int J Antimicrob Agents; 2007 Jul; 30(1):83-6. PubMed ID: 17512703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European Borrelia burgdorferi isolated from humans and ticks culture conditions and antibiotic susceptibility.
    Preac-Mursic V; Wilske B; Schierz G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Dec; 263(1-2):112-8. PubMed ID: 3577473
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Koetsveld J; Manger A; Hoornstra D; Draga RO; Oei A; Kolyasnikova NM; Toporkova MG; Sarksyan DS; Wagemakers A; Platonov AE; Hovius JW
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661882
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro susceptibility of isolates of Borrelia burgdorferi s.l. to antimicrobial agents.
    Santino I; Scazzocchio F; Ciceroni L; Ciarrocchi S; Sessa R; Del Piano M
    Int J Immunopathol Pharmacol; 2006; 19(3):545-9. PubMed ID: 17026839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know.
    Hunfeld KP; Brade V
    Wien Klin Wochenschr; 2006 Nov; 118(21-22):659-68. PubMed ID: 17160604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Borrelia burgdorferi Group: in-vitro antibiotic sensitivity].
    Henneberg JP; Neubert U
    Orv Hetil; 2002 May; 143(21):1195-8. PubMed ID: 12073540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.